These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8054279)

  • 61. Increased tyrosine protein kinase activity in hairy cell and monocytic leukemias.
    Lower EE; Franco RS; Martelo OJ
    Am J Med Sci; 1992 Jun; 303(6):387-91. PubMed ID: 1605167
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).
    Harbeck N; Kates RE; Look MP; Meijer-Van Gelder ME; Klijn JG; Krüger A; Kiechle M; Jänicke F; Schmitt M; Foekens JA
    Cancer Res; 2002 Aug; 62(16):4617-22. PubMed ID: 12183417
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours.
    de Witte JH; Foekens JA; Brünner N; Heuvel JJ; van Tienoven T; Look MP; Klijn JG; Geurts-Moespot A; Grebenchtchikov N; Benraad T; Sweep CG
    Br J Cancer; 2001 Jul; 85(1):85-92. PubMed ID: 11437407
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
    Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
    Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.
    Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H
    Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tyrosine protein kinases and their substrates in human leukemia cells.
    Wickremasinghe RG; Piga A; Mire AR; Taheri MR; Yaxley JC; Hoffbrand AV
    Leuk Res; 1985; 9(12):1443-50. PubMed ID: 4079454
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Two separate tyrosine protein kinases in human platelets.
    Nakamura S; Takeuchi F; Tomizawa T; Takasaki N; Kondo H; Yamamura H
    FEBS Lett; 1985 May; 184(1):56-9. PubMed ID: 4039273
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy.
    Hussain HA; Harvey AJ
    World J Clin Oncol; 2014 Aug; 5(3):299-310. PubMed ID: 25114846
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results.
    Bolla M; Rostaing-Puissant B; Bottari SP; Chedin M; Marron-Charriere J; Colonna M; Berland E; Chambaz E
    Breast Cancer Res Treat; 1996; 39(3):327-34. PubMed ID: 8877013
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens.
    Lower EE; Franco RS; Miller MA; Martelo OJ
    Breast Cancer Res Treat; 1993; 26(3):217-24. PubMed ID: 7504533
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
    Foekens JA; Peters HA; Look MP; Portengen H; Schmitt M; Kramer MD; Brünner N; Jänicke F; Meijer-van Gelder ME; Henzen-Logmans SC; van Putten WL; Klijn JG
    Cancer Res; 2000 Feb; 60(3):636-43. PubMed ID: 10676647
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.
    Foekens JA; Schmitt M; van Putten WL; Peters HA; Bontenbal M; Jänicke F; Klijn JG
    Cancer Res; 1992 Nov; 52(21):6101-5. PubMed ID: 1394237
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
    Romain S; Chinot O; Klijn JG; van Putten WL; Guirou O; Look M; Martin PM; Foekens JA
    Br J Cancer; 1994 Aug; 70(2):304-8. PubMed ID: 8054279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DNA-synthesis enzyme activity: a biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?
    Romain S; Martin PM; Klijn JG; van Putten WL; Look MP; Guirou O; Foekens JA
    Int J Cancer; 1997 Apr; 74(2):156-61. PubMed ID: 9133448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
    Foekens JA; Schmitt M; van Putten WL; Peters HA; Kramer MD; Jänicke F; Klijn JG
    J Clin Oncol; 1994 Aug; 12(8):1648-58. PubMed ID: 8040677
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.